This inventor holds 1 USPTO granted patent and 7 published patent applications. Top assignee: Syntekabio, Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Hyung Jun Kwon: Innovator in Pharmaceutical Composition
Introduction
Hyung Jun Kwon is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the fight against viral infections. His innovative work has led to the development of a composition aimed at preventing or treating SARS coronavirus 2 infection disease.
Latest Patents
Hyung Jun Kwon holds one patent, which is a pharmaceutical composition for preventing or treating severe acute respiratory syndrome coronavirus 2 infection disease. This composition comprises a compound represented by a Chemical Formula 1, or a pharmaceutically acceptable salt thereof, as an active ingredient. This invention is crucial in addressing the challenges posed by the SARS coronavirus.
Career Highlights
Kwon is currently associated with Syntekabio, Inc., where he continues to engage in groundbreaking research and development. His work at the company reflects his commitment to advancing medical science and improving public health outcomes.
Collaborations
Some of his coworkers include Jong Sun Jung and Jong Hui Hong, who contribute to the collaborative efforts in their research endeavors.
Conclusion
Hyung Jun Kwon's innovative contributions to pharmaceutical compositions highlight his role as a key inventor in the fight against viral diseases. His work not only showcases his expertise but also emphasizes the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile